Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3850344 | American Journal of Kidney Diseases | 2009 | 19 Pages |
Abstract
Currently, there are insufficient data to establish the comparative superiority of non-calcium-binding agents over calcium-containing phosphate binders for such important patient-level outcomes as all-cause mortality and cardiovascular end points. Additional trials are still required to examine the differential effects of phosphate-binding agents on these end points and the mineral homeostasis pathway.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Sankar D. MD, MPH, Suetonia C. MBChB, Jonathan C. MBChB, PhD, Grahame J. PhD, Giovanni F.M. MD, PhD, MPH, MM,